Such immunosuppressive microenvironment inhibits the infiltration of antitumor CD8+ T-cells and is associated with poor response to treatment and poor prognosis of sarcoma (Song et al., 2020; Balkwill, 2020). Here, CD8A is linked to sarcoma.